Trial Profile
A Study to Evaluate the Efficacy and Safety of Abacavir+Lamivudine+Unboosted Atazanavir (ABC/3TC+ATV) in Patients With HIV Infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2019
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Lamivudine/abacavir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 01 Mar 2016 New trial record